In November 2016, the Royal Pharmaceutical Society (RPS) launched its campaign 'Pharmacist-led care of people with long term conditions’, which calls for the full utilisation of pharmacists’ expertise and clinical knowledge to help people with long-term conditions achieve the best outcomes from their medicines and make more efficient use of NHS resources. The Pharmaceutical Journal marks the launch of this campaign with a special report on long-term conditions, which shows how pharmacists can support patients living with conditions such as diabetes, COPD and atrial fibrillation, from detection through to management and monitoring.
Submit a paper
We are calling for article submissions that highlight best practice in relation to the management of long-term conditions.
Around 12,500 strokes are caused by atrial fibrillation (AF) in the UK each year, and 7,100 of these are preventable with appropriate anticoagulation. Four new oral anticoagulants (NOACs) are now available in the UK in addition to warfarin.
Examining the impact of sub-optimal inhaler technique and how healthcare professionals can support patients in optimising their technique.
Risk stratification and ongoing care is important in non-ST elevation acute coronary syndrome, the new collective term for unstable angina and non-ST elevation myocardial infarction.
Sickle cell disease is the most common inherited blood disorder in the UK, affecting 12,000–15,000 people, and although it is a life-shortening condition, its symptoms and complications can be effectively managed.
A lack of funding for research into chronic obstructive pulmonary disease, as well as difficulties in conducting clinical trials, make finding new treatments for this respiratory condition challenging. But there are glimmers of hope, such as reversing steroid resistance and identifying subpopulations of patients in order to speed up clinical trials.
Seeking a cure for HIVSubscription
Efforts to find a cure for HIV were reinvigorated in 2008 when the case of Timothy Ray Brown showed that a cure is possible. Researchers and pharmaceutical companies are now seeking out the virus in its hiding places in an attempt to eradicate it completely.
Personalised treatment for depression on the horizon: predicting response to antidepressantsSubscription
Only one-third of patients with depression benefit from the first antidepressant they try, but researchers are striving to find biological features that predict how a person will respond to particular drugs so they can tailor treatment from the beginning.
Conventional therapies and emergent precision medicines for cystic fibrosis: challenges and opportunitiesSubscription
Around 27 years ago, the discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene – responsible for causing cystic fibrosis (CF) – marked a significant moment in the history of the condition. Despite the early promise of this target for gene therapy, a universally successful treatment has proven elusive in the ensuing years. While clinical trials involving gene therapy continue to make progress, the ‘magic bullet’ remains some way off. Survival continues to ...
Primary prevention of cardiovascular disease with statins: assessing the evidence base behind clinical guidanceSubscription
Statins and other cholesterol-lowering drugs are increasingly being used for primary prevention of atherosclerotic cardiovascular disease. Three lines of evidence inform the development of therapeutic goals for both drug and lifestyle intervention. This evidence reveals the following principles for cholesterol lowering in primary prevention: (a) ‘the more (lowering), the better’ for relative risk reduction, (b) ‘the lower, the better’ for absolute risk reduction, and (c) ‘the earlier, ...
A patient came into our pharmacy requesting an emergency supply of a salbutamol inhaler recently. He lives elsewhere but was working locally. We accessed his summary care record (SCR) and, to our surprise, discovered that he had not been prescribed anything since 2015. Before then, he was regularly prescribed beclomethasone and salbutamol inhalers. In addition, the surgery details he provided were incorrect.
I would like to highlight the devastating consequences that delayed referrals are having on people with inflammatory arthritis.
Asthma and chronic obstructive pulmonary disease (COPD) continue to account for a large burden of disease in the UK. Despite comprehensive guidelines, more than 1,000 people die from asthma each year and COPD accounts for a leading cause of emergency admissions in the UK. In a joint initiative between NHS City and Hackney clinical commissioning group and the local tertiary centre for respiratory disease Barts Health NHS Trust, asthma and COPD reviews were undertaken by a specialist ...
Anti-cytokine drugs typically prescribed to treat inflammatory conditions, such as rheumatoid arthritis and psoriasis, can also improve symptoms of depression, according to new research.
The number of prescriptions for drugs to treat type 2 diabetes dispensed by community pharmacies in England rose by 33% over the past five years, according to research carried out by EXASOL, a database developer and analytics company.
Four types of commonly prescribed blood pressure medicines may have an impact on mood disorders such as depression or bipolar disorder, according to research.
High doses of some non-steroidal anti-inflammatory drugs can double the risk of being admitted to hospital for heart failure.
An early trial of the experimental oral asthma therapy fevipiprant has shown it is effective in reducing airway inflammation among patients with persistent eosinophilic asthma.
A review scheme led by a team of pharmacists prevented an estimated 886 strokes in patients with atrial fibrillation.
Questionnaires sent to 112 patients with diabetes across 24 GP surgeries reveal a reluctance to improve lifestyle, as well as a lack of understanding about HbA1c levels.
When used during respiratory illness in children, paracetamol is not associated with a higher risk of asthma exacerbations than ibuprofen.
Regina Ahmed has decided to try a career in the primary care sector. In the first of a series of blog posts, she describes her first impressions of the role.
RPS 'delighted' with proposed changes to supervision of pharmacists training to be prescribersSubscription
Sandra Gidley, chair of the RPS English Pharmacy Board, says the RPS is surprised and delighted to see the GPhC consultation document proposing changes to the supervision of pharmacists training to be prescribers
A new campaign calling for pharmacists to have a significant role in supporting people with long-term conditions is being launched by the Royal Pharmaceutical Society.